S66 Diagnosis and Treatment of Adult Male Hypogonadism

Program: Symposia
Clinical Session
Monday, April 4, 2016: 11:45 AM-1:15 PM
Room 210 (BCEC)
Chair:
Frederick C. W. Wu, M.D., FRCP, University of Manchester, Manchester, United Kingdom

Disclosures:
FCWW: Consultant, Repros Therapeutics, Investigator, Besins Healthcare, Speaker, Besins Healthcare.
11:45 AM
Claus H. Gravholt, MD, PhD, Department of Internal Medicine and Endocrinology, Aarhus University Hospital, Aarhus C, Denmark
Nothing to Disclose: CHG
12:15 PM
Shalender Bhasin, MD, Men's Health, Aging and Metabolism, Brigham and Women's Hospital-Harvard Medical School, Boston, MA
Nothing to Disclose: SB
12:45 PM
Mathis Grossmann, MD, PhD, FRACP, Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, Australia
Nothing to Disclose: MG
See more of: Symposia

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire